New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 4, 2012
12:41 EDTQGENQIAGEN reaffirms FY12 EPS view $1.04-1.06, consensus $1.00
Sees revenue up approximately 8-9% CER on a mix of contributions from the acquisitions of Cellestis and Ipsogen in 2011 and AmniSure in May 2012, as well as growth in the rest of the business. Full-year reported sales are expected to be adversely affected by currency movements against the U.S. dollar, QIAGEN's reporting currency.This guidance takes into account approximately half a cent of dilution expected on adjusted EPS results in the fourth quarter of 2012 from the combined effect of the share repurchase program as well as higher interest expenses incurred through the U.S. private placement. These expectations do not take into account any further acquisitions that could be completed in 2012.
News For QGEN From The Last 14 Days
Check below for free stories on QGEN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
16:17 EDTQGENQIAGEN acquires exclusive global license to the biomarker SF3B1
Subscribe for More Information
July 15, 2014
16:05 EDTQGENQIAGEN launches 14 new cancer gene panels
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use